APA (7th ed.) Citation

Polivkova, V., Rohon, P., Klamova, H., Cerna, O., Divoka, M., Curik, N., . . . Polakova, K. M. Interferon-α Revisited: Individualized Treatment Management Eased the Selective Pressure of Tyrosine Kinase Inhibitors on BCR-ABL1 Mutations Resulting in a Molecular Response in High-Risk CML Patients. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Polivkova, Vaclava, et al. Interferon-α Revisited: Individualized Treatment Management Eased the Selective Pressure of Tyrosine Kinase Inhibitors on BCR-ABL1 Mutations Resulting in a Molecular Response in High-Risk CML Patients. Public Library of Science (PLoS).

MLA (9th ed.) Citation

Polivkova, Vaclava, et al. Interferon-α Revisited: Individualized Treatment Management Eased the Selective Pressure of Tyrosine Kinase Inhibitors on BCR-ABL1 Mutations Resulting in a Molecular Response in High-Risk CML Patients. Public Library of Science (PLoS).